Details of the Drug

General Information of Drug (ID: DMME0MV)

• Drug Name: NBTXR3

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 1/2	[1]

• Cross-matching ID:
  PubChem CID: 159422
  TTD ID: D02YEO

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)